Minimal SN Tumor Burden

296 participants · First posted Sep 16, 2013

Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic Syndrome

12 participants · First posted Oct 28, 2016

Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer

30 participants · First posted Apr 6, 2006

Sacituzumab Govitecan(Trodelvy)

C₂₂H₂₀N₂O₅ · Rx

SN-001

SN-011

INFLECTIS BIOSCIENCE

France

Lexaria Bioscience

United States

Aytu BioScience

United States

SN BioScience's SNB-101 Receives FDA IND Clearance for Phase 1b/2 Trial in Extensive Stage Small Cell Lung Cancer

SN BioScience Secures FDA Orphan Drug Designation for Nanoparticle Cancer Drug SNB-101 in Gastric Cancer

SN BioScience Initiates Global Phase 1b/2 Trial of SNB-101 for Small Cell Lung Cancer with Zero High-Grade Diarrhea Events